Awarded
ADQUISICIÓN DEL MEDICAMENTO EXCLUSIVO: UBLITUXIMAB (BRIUMVI).
Original language: Spanish
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- Neuraxpharm Spain, S.L.U.
- Contract value
- €215,941
- Bids received
- 1
- Published
- 12 Jan 2026
- Awarded
- 9 Dec 2025
- Contract start
- 9 Dec 2025
- Contract end
- 26 Dec 2026estimated
- Region
- Madrid